Natural killer cells aren't just mindless defenders — a special type, adaptive NK cells, remember their enemies and come back ...

A Stage 4 cancer survivor is grateful for a 'lifesaving' clinical trial, but experts are wary over potential federal funding ...

T cell therapy called AIC100, which targets the ICAM-1 protein, demonstrated encouraging responses and an acceptable safety ...

T cell therapy called AIC100, which targets the ICAM-1 protein, demonstrated encouraging responses and an acceptable safety profile in patients with two types of advanced thyroid cancer, according to ...